Publications by authors named "Thomas Huizinga"

Claim this Profile
A
A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis.
Sophie Wolfgramm, Sara Alehashemi, Martin Wendlandt, Franziska G Thiel, Adriana A de Jesus, Thomas W J Huizinga

Ann Rheum Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024.
Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, John D Isaacs, Philip Mease, Thomas Huizinga

Ann Rheum Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study.
Paul Emery, Roy Fleischmann, Robert Wong, Karissa Lozenski, Yoshiya Tanaka, Thomas W J Huizinga

J Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab biosimilar GP1111: a review of 5 years' post-approval experience.
Thomas W J Huizinga, Valeria Dipasquale, Markus Zabransky, Jens Heyn, Claudio Romano

Expert Opin Biol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Andrew P Cope, Marianna Jasenecova, Joana C Vasconcelos, Andrew Filer, Karim Raza, Thomas Huizinga

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners.
Miles D Holborough-Kerkvliet, Greta Mucignato, Sam J Moons, Venetia Psomiadou, Rohit S R Konada, Thomas Huizinga

Glycobiology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.
Thomas Huizinga, Ernest Choy, Amy Praestgaard, Hubert van Hoogstraten, Patrick R LaFontaine

Rheumatol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis.
Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Thomas W J Huizinga, Gustavo Citera

Rheumatol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Glycobiology of rheumatic diseases.
Theresa Kissel, René E M Toes, Thomas W J Huizinga, Manfred Wuhrer

Nat Rev Rheumatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study.
Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas W J Huizinga

Arthritis Res Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Genetics in Clinically Suspect Arthralgia and Rheumatoid Arthritis Development: A Large Cross-Sectional Study.
Marc P Maurits, Fenne Wouters, Ellis Niemantsverdriet, Thomas W J Huizinga, Erik B van den Akker

Arthritis Rheumatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycobiology of rheumatic diseases.
Theresa Kissel, René E M Toes, Thomas W J Huizinga, Manfred Wuhrer

Nat Rev Rheumatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Thomas Wj Huizinga

RMD Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis.
Gerd R Burmester, Vivian P Bykerk, Maya H Buch, Yoshiya Tanaka, Hideto Kameda, Thomas Huizinga

Rheumatology (Oxford)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients.
Imane Abouyahya, Sophie I E Liem, Zahir Amoura, João Eurico Fonseca, Benjamin Chaigne, Thomas W J Huizinga

Clin Exp Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A framework for employing longitudinally collected multicenter electronic health records to stratify heterogeneous patient populations on disease history.
Marc P Maurits, Ilya Korsunsky, Soumya Raychaudhuri, Shawn N Murphy, Jordan W Smoller, Thomas W J Huizinga

J Am Med Inform Assoc· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept.
Harris A Ahmad, Joshua F Baker, Philip G Conaghan, Paul Emery, Thomas W J Huizinga

Arthritis Res Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left Ventricular Systolic Function in Patients with Systemic Lupus Erythematosus and Its Association with Cardiovascular Events.
Tea Gegenava, Maka Gegenava, Gerda M Steup-Beekman, Thomas W J Huizinga, Jeroen J Bax

J Am Soc Echocardiogr· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.
Mariam Al-Laith, Marianna Jasenecova, Sonya Abraham, Aisla Bosworth, Ian N Bruce, Thomas W J Huizinga

Trials· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis".
Mikhail Volkov, Jacqueline Dekkers, Bruno G Loos, Sergio Bizzarro, Thomas W J Huizinga

Sci Transl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study.
Michael Schiff, Bernard Combe, Thomas Dörner, Joel M Kremer, Thomas W Huizinga

RMD Open· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.
Frank Behrens, Paul P Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W Huizinga

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort.
Iuliia Biliavska, Tanja A Stamm, Jose Martinez-Avila, Thomas W J Huizinga, Robert B M Landewé

Ann Rheum Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
Shintaro Hirata, Linda Dirven, Yijing Shen, Michael Centola, Guy Cavet, Thomas W J Huizinga

Rheumatology (Oxford)· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Just another case of Sjogren's syndrome?
Leroy R Lard, Thomas W J Huizinga

J Rheumatol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis